Home
Conditions
Lymphoma, B-Cell

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Not Yet Recruiting

Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients

NCT07714421

Conditions: Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not Yet Recruiting

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

NCT07713459

Conditions: CAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)

NCT07712588

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Hunan Cancer Hospital Changsha, Hunan, China

Cancer Hospital of Shandong Frist Medical University Jinan, Shangdong, China

View Trial Details

Not Yet Recruiting

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

NCT07711327

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Fibrillation (AF), +35 more
Locations: City of Hope Duarte, California, United States

UC San Diego Health San Diego, California, United States

Stanford Health Care Stanford, California, United States

View Trial Details

Not Yet Recruiting

Pre-emptive Anakinra for Cytokine Event Reduction

NCT06703216

Conditions: B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Not Yet Recruiting

A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma

NCT07705308

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

Fudan University Affiliated Minhang Hospital Shanghai, Shanghai Municipality, China

Huadong Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP

NCT07702851

Conditions: Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment

NCT07638722

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT07599423

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")

NCT07649304

Conditions: AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +18 more
Locations: Not specified

View Trial Details

Lymphoma, B-Cell

Lymphoma, B-Cell trial results

Related conditions